{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,14]],"date-time":"2024-08-14T15:10:20Z","timestamp":1723648220191},"reference-count":15,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,1,24]]},"DOI":"10.7759\/cureus.21571","type":"journal-article","created":{"date-parts":[[2022,1,25]],"date-time":"2022-01-25T03:56:39Z","timestamp":1643082999000},"source":"Crossref","is-referenced-by-count":2,"title":["Early Flare-Ups of Myasthenia Gravis After Thoracoscopic Thymectomy in a Patient Recently Receiving BNT162b2 mRNA COVID-19 Vaccination"],"prefix":"10.7759","author":[{"given":"Permphan","family":"Dharmasaroja","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2019.116428","article-title":"Myasthenia gravis: historical achievements and the \"golden age\" of clinical trials","volume":"406","author":"Nguyen-Cao TM","year":"2019","unstructured":"Nguyen-Cao TM, Gelinas D, Griffin R, Mondou E. Myasthenia gravis: historical achievements and the \"golden age\" of clinical trials. J Neurol Sci. 2019, 406:116428. 10.1016\/j.jns.2019.116428","journal-title":"J Neurol Sci"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1007\/s13760-019-01252-x","article-title":"Late-onset generalized myasthenia gravis: clinical features, treatment, and outcome","volume":"120","author":"Celik SY","year":"2020","unstructured":"Celik SY, Durmus H, Yilmaz V, Direskeneli GS, Parman YG, Oflazer PS, Deymeer F. Late-onset generalized myasthenia gravis: clinical features, treatment, and outcome. Acta Neurol Belg. 2020, 120:133-40. 10.1007\/s13760-019-01252-x","journal-title":"Acta Neurol Belg"},{"key":"ref3","article-title":"[Thymic abnormalities in patients with myasthenia gravis]","volume":"63","author":"Utsugisawa K","year":"2011","unstructured":"Utsugisawa K, Nagane Y. [Thymic abnormalities in patients with myasthenia gravis]. Brain Nerve. 2011, 63:685-94.","journal-title":"Brain Nerve"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1602489","article-title":"Randomized trial of thymectomy in myasthenia gravis","volume":"375","author":"Wolfe GI","year":"2016","unstructured":"Wolfe GI, Kaminski HJ, Aban IB, et al.. Randomized trial of thymectomy in myasthenia gravis. N Engl J Med. 2016, 375:511-22. 10.1056\/NEJMoa1602489","journal-title":"N Engl J Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.17712\/nsj.2021.1.20190041","article-title":"Prevalence and risk factors of myasthenia gravis recurrence post-thymectomy","volume":"26","author":"Alqarni F","year":"2021","unstructured":"Alqarni F, Almalki D, Aljohani Z, et al.. Prevalence and risk factors of myasthenia gravis recurrence post-thymectomy. Neurosciences (Riyadh). 2021, 26:4-14. 10.17712\/nsj.2021.1.20190041","journal-title":"Neurosciences (Riyadh)"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines9050435","article-title":"Immune-mediated disease flares or new-onset disease in 27 subjects following mRNA\/DNA SARS-CoV-2 vaccination","volume":"9","author":"Watad A","year":"2021","unstructured":"Watad A, De Marco G, Mahajna H, et al.. Immune-mediated disease flares or new-onset disease in 27 subjects following mRNA\/DNA SARS-CoV-2 vaccination. Vaccines (Basel). 2021, 9:435. 10.3390\/vaccines9050435","journal-title":"Vaccines (Basel)"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.15581","article-title":"A case of COVID-19 vaccine causing a myasthenia gravis crisis","volume":"13","author":"Tagliaferri AR","year":"2021","unstructured":"Tagliaferri AR, Narvaneni S, Azzam MH, Grist W. A case of COVID-19 vaccine causing a myasthenia gravis crisis. Cureus. 2021, 13:e15581. 10.7759\/cureus.15581","journal-title":"Cureus"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines9101112","article-title":"COVID-19 vaccination in patients with myasthenia gravis: a single-center case series","volume":"9","author":"Ruan Z","year":"2021","unstructured":"Ruan Z, Tang Y, Li C, Sun C, Zhu Y, Li Z, Chang T. COVID-19 vaccination in patients with myasthenia gravis: a single-center case series. Vaccines (Basel). 2021, 9:1112. 10.3390\/vaccines9101112","journal-title":"Vaccines (Basel)"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1002\/mus.26689","article-title":"Factors associated with acute exacerbations of myasthenia gravis","volume":"60","author":"Gummi RR","year":"2019","unstructured":"Gummi RR, Kukulka NA, Deroche CB, Govindarajan R. Factors associated with acute exacerbations of myasthenia gravis. Muscle Nerve. 2019, 60:693-9. 10.1002\/mus.26689","journal-title":"Muscle Nerve"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(20)30413-0","article-title":"COVID-19-associated risks and effects in myasthenia gravis (CARE-MG)","volume":"19","author":"Muppidi S","year":"2020","unstructured":"Muppidi S, Guptill JT, Jacob S, et al.. COVID-19-associated risks and effects in myasthenia gravis (CARE-MG). Lancet Neurol. 2020, 19:970-1. 10.1016\/S1474-4422(20)30413-0","journal-title":"Lancet Neurol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000018622","article-title":"Risk factors of myasthenia crisis after thymectomy among myasthenia gravis patients: a meta-analysis","volume":"99","author":"Geng Y","year":"2020","unstructured":"Geng Y, Zhang H, Wang Y. Risk factors of myasthenia crisis after thymectomy among myasthenia gravis patients: a meta-analysis. Medicine (Baltimore). 2020, 99:e18622. 10.1097\/MD.0000000000018622","journal-title":"Medicine (Baltimore)"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1007\/s12026-016-8819-5","article-title":"Adjuvants- and vaccines-induced autoimmunity: animal models","volume":"65","author":"Ruiz JT","year":"2017","unstructured":"Ruiz JT, Luj\u00e1n L, Blank M, Shoenfeld Y. Adjuvants- and vaccines-induced autoimmunity: animal models. Immunol Res. 2017, 65:55-65. 10.1007\/s12026-016-8819-5","journal-title":"Immunol Res"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2020.1818519","article-title":"The role of the thymus in COVID-19 disease severity: implications for antibody treatment and immunization","volume":"17","author":"Kellogg C","year":"2021","unstructured":"Kellogg C, Equils O. The role of the thymus in COVID-19 disease severity: implications for antibody treatment and immunization. Hum Vaccin Immunother. 2021, 17:638-43. 10.1080\/21645515.2020.1818519","journal-title":"Hum Vaccin Immunother"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.178.3.1845","article-title":"Prednisolone dose-dependently influences inflammation and coagulation during human endotoxemia","volume":"178","author":"de Kruif MD","year":"2007","unstructured":"de Kruif MD, Lemaire LC, Giebelen IA, et al.. Prednisolone dose-dependently influences inflammation and coagulation during human endotoxemia. J Immunol. 2007, 178:1845-51. 10.4049\/jimmunol.178.3.1845","journal-title":"J Immunol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1038\/s41420-021-00429-9","article-title":"Plasma IL-6 levels following corticosteroid therapy as an indicator of ICU length of stay in critically ill COVID-19 patients","volume":"7","author":"Awasthi S","year":"2021","unstructured":"Awasthi S, Wagner T, Venkatakrishnan AJ, et al.. Plasma IL-6 levels following corticosteroid therapy as an indicator of ICU length of stay in critically ill COVID-19 patients. Cell Death Discov. 2021, 7:55. 10.1038\/s41420-021-00429-9","journal-title":"Cell Death Discov"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/83300-early-flare-ups-of-myasthenia-gravis-after-thoracoscopic-thymectomy-in-a-patient-recently-receiving-bnt162b2-mrna-covid-19-vaccination","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:42:48Z","timestamp":1707507768000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/83300-early-flare-ups-of-myasthenia-gravis-after-thoracoscopic-thymectomy-in-a-patient-recently-receiving-bnt162b2-mrna-covid-19-vaccination"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,24]]},"references-count":15,"URL":"https:\/\/doi.org\/10.7759\/cureus.21571","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1,24]]}}}